These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 15144595

  • 21. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
    Elder DJ, Halton DE, Hague A, Paraskeva C.
    Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
    [Abstract] [Full Text] [Related]

  • 22. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K.
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [Abstract] [Full Text] [Related]

  • 23. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.
    Li S, Tong Q, Zhang W, Wang Q, Chen Z, Wu Q.
    Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952
    [Abstract] [Full Text] [Related]

  • 24. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
    Zhang H, Ye Y, Bai Z, Wang S.
    Dig Dis Sci; 2008 Aug; 53(8):2195-203. PubMed ID: 18320325
    [Abstract] [Full Text] [Related]

  • 25. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S, Inoue H, Flowers LC, Sidell N.
    Clin Cancer Res; 2003 Oct 01; 9(12):4627-35. PubMed ID: 14555539
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Regulation of cyclooxygenase-2 expression in bovine chondrocytes in culture by interleukin 1alpha, tumor necrosis factor-alpha, glucocorticoids, and 17beta-estradiol.
    Morisset S, Patry C, Lora M, de Brum-Fernandes AJ.
    J Rheumatol; 1998 Jun 01; 25(6):1146-53. PubMed ID: 9632078
    [Abstract] [Full Text] [Related]

  • 32. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T, Watanabe M, Hasegawa H, Nishibori H, Ishii Y, Tatematsu H, Yamamoto K, Kubota T, Kitajima M.
    Anticancer Res; 2003 Jun 01; 23(1A):245-9. PubMed ID: 12680220
    [Abstract] [Full Text] [Related]

  • 33. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM.
    Cancer Res; 2000 Dec 15; 60(24):6846-50. PubMed ID: 11156377
    [Abstract] [Full Text] [Related]

  • 34. Resistance of prostate cancer cell lines to COX-2 inhibitor treatment.
    Wagner M, Loos J, Weksler N, Gantner M, Corless CL, Barry JM, Beer TM, Garzotto M.
    Biochem Biophys Res Commun; 2005 Jul 08; 332(3):800-7. PubMed ID: 15907789
    [Abstract] [Full Text] [Related]

  • 35. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells.
    Di Popolo A, Memoli A, Apicella A, Tuccillo C, di Palma A, Ricchi P, Acquaviva AM, Zarrilli R.
    Oncogene; 2000 Nov 16; 19(48):5517-24. PubMed ID: 11114729
    [Abstract] [Full Text] [Related]

  • 36. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G.
    FASEB J; 2001 Dec 16; 15(14):2742-4. PubMed ID: 11606477
    [Abstract] [Full Text] [Related]

  • 37. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
    Chen WC, McBride WH, Chen SM, Lee KF, Hwang TZ, Jung SM, Shau H, Liao SK, Hong JH, Chen MF.
    Head Neck; 2005 Jun 16; 27(6):503-12. PubMed ID: 15772955
    [Abstract] [Full Text] [Related]

  • 38. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X, Yue P, Zhou Z, Khuri FR, Sun SY.
    J Natl Cancer Inst; 2004 Dec 01; 96(23):1769-80. PubMed ID: 15572759
    [Abstract] [Full Text] [Related]

  • 39. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B, Deutsch E, Eschwege P, De Crevoisier R, Nasr E, Eschwege F, Bourhis J.
    J Urol; 2003 Nov 01; 170(5):2036-9. PubMed ID: 14532848
    [Abstract] [Full Text] [Related]

  • 40. The effect of cyclooxygenase inhibitor diclofenac on experimental murine colon carcinoma.
    Falkowski M, Skogstad S, Shahzidi S, Smedsröd B, Sveinbjörnsson B.
    Anticancer Res; 2003 Nov 01; 23(3B):2303-8. PubMed ID: 12894507
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.